AwesomeCapital
Thursday, February 27, 2020
Apellis Pharmaceuticals EPS beats by $0.49
Apellis Pharmaceuticals (NASDAQ:
APLS
): Q4 GAAP EPS of -$0.65
beats by $0.49
.
Cash and cash equivalents of $352M
Press Release
https://seekingalpha.com/news/3546824-apellis-pharmaceuticals-eps-beats-0_49
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
‹
›
Home
View web version
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.